Loading…
Details
- Instance of
- type of disease
- Subclass of
- esophageal disease, thoracic disease
- afflicts
- esophagus
- drug or therapy used for treatment
- esomeprazole, lansoprazole, omeprazole, pantoprazole, sucralfate, denosumab, pantoprazole sodium, dexlansoprazole
- health specialty
- gastroenterology
- ICD-9-CM
- 530.10, 530.1, 530.12
Connected on Wikidata
Subject of
- a4b7 Integrin in Eosinophilic Esophagitis
- Management of Esophagitis Following Repair of Esophageal Atresia
- Effects of Swallowed Steroids on Bone Density and Growth in Pediatric Eosinophilic Esophagitis
- Efficacy and Safety of LXI-15028 Comparing With Esomeprazole in the Treatment of Erosive Esophagitis
- Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been Healed
- Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis
- Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis
- Reflux Esophagitis Phase III Study (Maintenance Treatment)
- Reflux Esophagitis Phase III Study (Initial Treatment)
- A Study of Flovent in Patients With Eosinophilic Esophagitis
Nothing in the MetaHistoryBook collection references this item yet.